Review



curcumin analog c1  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    MedChemExpress curcumin analog c1
    <t>A.</t> <t>Lysosomal</t> acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog <t>C1.</t> The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.
    Curcumin Analog C1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 96 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/curcumin+analog+c1/Curcumin/bio_rxiv__2025__08__29__672259-194-5-11
    Average 96 stars, based on 96 article reviews
    curcumin analog c1 - by Bioz Stars, 2026-08
    96/100 stars

    Images

    1) Product Images from "G3BP1 Maintains Lysosomal Homeostasis to Limit Tau Aggregate Accumulation"

    Article Title: G3BP1 Maintains Lysosomal Homeostasis to Limit Tau Aggregate Accumulation

    Journal: bioRxiv

    doi: 10.1101/2025.08.29.672259

    A. Lysosomal acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog C1. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.
    Figure Legend Snippet: A. Lysosomal acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog C1. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.

    Techniques Used: Expressing

    A schematic model illustrating the differences in lysosomal homeostasis between WT and G3BP1 KO cells. In WT cells (upper panels), G3BP1 cooperates with ESCRT and other factors to repair damaged lysosomes and enhance lysosomal activity, thereby promoting the degradation of Tau aggregates and PFFs. In contrast, in G3BP1 KO cells, these functions are impaired, leading to reduced lysosomal activity and the accumulation of Tau aggregates. However, activation of TFEB by the curcumin analog C1 promotes lysosomal biogenesis and suppresses the accumulation of Tau aggregates.
    Figure Legend Snippet: A schematic model illustrating the differences in lysosomal homeostasis between WT and G3BP1 KO cells. In WT cells (upper panels), G3BP1 cooperates with ESCRT and other factors to repair damaged lysosomes and enhance lysosomal activity, thereby promoting the degradation of Tau aggregates and PFFs. In contrast, in G3BP1 KO cells, these functions are impaired, leading to reduced lysosomal activity and the accumulation of Tau aggregates. However, activation of TFEB by the curcumin analog C1 promotes lysosomal biogenesis and suppresses the accumulation of Tau aggregates.

    Techniques Used: Activity Assay, Activation Assay



    Similar Products

    curcumin analog c1  (MedChemExpress)
    96
    MedChemExpress curcumin analog c1
    <t>A.</t> <t>Lysosomal</t> acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog <t>C1.</t> The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.
    Curcumin Analog C1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/curcumin+analog+c1/Curcumin/bio_rxiv__2025__08__29__672259-194-5-11
    Average 96 stars, based on 1 article reviews
    curcumin analog c1 - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    n4779 curcumin analog c1 selleckchem  (Selleck Chemicals)
    93
    Selleck Chemicals n4779 curcumin analog c1 selleckchem
    <t>A.</t> <t>Lysosomal</t> acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog <t>C1.</t> The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.
    N4779 Curcumin Analog C1 Selleckchem, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/curcumin+analog+c1/Curcumin+analog+C1/pm41558486-268-149-153
    Average 93 stars, based on 1 article reviews
    n4779 curcumin analog c1 selleckchem - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    tfeb activator c1 treatment c1  (Selleck Chemicals)
    93
    Selleck Chemicals tfeb activator c1 treatment c1
    <t>A.</t> <t>Lysosomal</t> acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog <t>C1.</t> The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.
    Tfeb Activator C1 Treatment C1, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/curcumin+analog+c1/Curcumin+analog+C1/pm39875050-103-30-39
    Average 93 stars, based on 1 article reviews
    tfeb activator c1 treatment c1 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    curcumin analog c1  (Selleck Chemicals)
    93
    Selleck Chemicals curcumin analog c1
    <t>A.</t> <t>Lysosomal</t> acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog <t>C1.</t> The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.
    Curcumin Analog C1, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/curcumin+analog+c1/Curcumin+analog+C1/pmc11655821-63-39-44
    Average 93 stars, based on 1 article reviews
    curcumin analog c1 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    erastin  (Selleck Chemicals)
    93
    Selleck Chemicals erastin
    <t>A.</t> <t>Lysosomal</t> acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog <t>C1.</t> The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.
    Erastin, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/curcumin+analog+c1/Curcumin+analog+C1/pmc11655821-63-37-44
    Average 93 stars, based on 1 article reviews
    erastin - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    curcumin analog c1  (Cayman Chemical)
    90
    Cayman Chemical curcumin analog c1
    <t>A.</t> <t>Lysosomal</t> acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog <t>C1.</t> The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.
    Curcumin Analog C1, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/curcumin+analog+c1/curcumin+analog+c1/pm37115208-98-33-36
    Average 90 stars, based on 1 article reviews
    curcumin analog c1 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A. Lysosomal acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog C1. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.

    Journal: bioRxiv

    Article Title: G3BP1 Maintains Lysosomal Homeostasis to Limit Tau Aggregate Accumulation

    doi: 10.1101/2025.08.29.672259

    Figure Lengend Snippet: A. Lysosomal acidification was assessed by measuring the uptake of the fluorescent dye pHLys Green in cells treated with the TFEB activator curcumin analog C1. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p** < 0.01, ns; not significant. B . Similarly, lysosomal abundance was measured using LysoPrime Deep Red. The data are presented as means ± SD ( n = 3). Statistical analysis was performed using Student’s t -test. p* < 0.05, p** < 0.01. C . Cells expressing TauRD-GFP were pretreated with the TFEB activator curcumin analog C1 for 24 h and then seeded with PFFs. Cells were subsequently treated with curcumin analog C1 for 48 h, followed by assessment of TauRD-GFP aggregation. D . Results of the TauRD-GFP aggregation assay in WT and G3BP1 KO cells are shown. Open bars (DMSO) represent DMSO-treated cells, and closed bars (C1) represent cells treated with curcumin analog C1. The data are expressed as means ± SD ( n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. p*** < 0.001, ns; not significant.

    Article Snippet: Lysosomal biogenesis was promoted using curcumin analog C1 (TFEB activator 1; MedChemExpress, Monmouth Junction, NJ).

    Techniques: Expressing

    A schematic model illustrating the differences in lysosomal homeostasis between WT and G3BP1 KO cells. In WT cells (upper panels), G3BP1 cooperates with ESCRT and other factors to repair damaged lysosomes and enhance lysosomal activity, thereby promoting the degradation of Tau aggregates and PFFs. In contrast, in G3BP1 KO cells, these functions are impaired, leading to reduced lysosomal activity and the accumulation of Tau aggregates. However, activation of TFEB by the curcumin analog C1 promotes lysosomal biogenesis and suppresses the accumulation of Tau aggregates.

    Journal: bioRxiv

    Article Title: G3BP1 Maintains Lysosomal Homeostasis to Limit Tau Aggregate Accumulation

    doi: 10.1101/2025.08.29.672259

    Figure Lengend Snippet: A schematic model illustrating the differences in lysosomal homeostasis between WT and G3BP1 KO cells. In WT cells (upper panels), G3BP1 cooperates with ESCRT and other factors to repair damaged lysosomes and enhance lysosomal activity, thereby promoting the degradation of Tau aggregates and PFFs. In contrast, in G3BP1 KO cells, these functions are impaired, leading to reduced lysosomal activity and the accumulation of Tau aggregates. However, activation of TFEB by the curcumin analog C1 promotes lysosomal biogenesis and suppresses the accumulation of Tau aggregates.

    Article Snippet: Lysosomal biogenesis was promoted using curcumin analog C1 (TFEB activator 1; MedChemExpress, Monmouth Junction, NJ).

    Techniques: Activity Assay, Activation Assay